BackIndia likely to approve two-dose regimen for Covid-19 vaccines, four weeks apart: Report
1 min read
03 Jan 2021, 08:34 AM IST
Experts at India's Central Drugs Standards Control Organisation (CDSCO) have already approved the vaccinesA final decision is expected to be announced by the agency's chief at a news conference scheduled today
PremiumNEW DELHI: India's drugs regulator is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally-developed one by Bharat Biotech, each four weeks apart, two sources with knowledge of the matter told Reuters on Saturday.
Experts at India's Central Drugs Standards Control Organisation (CDSCO) have already approved the vaccines and a final decision is expected to be announced by the agency's chief at a news conference scheduled on Sunday.
Calls to CDSCO were unanswered outside regular business hours.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!
Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint.
Download The Mint News App to get Daily Market Updates.
More
Less
Published: 03 Jan 2021, 08:33 AM IST
Next Story
